April 4 2009 --In September 2004, Photocure submitted to the United States Patent Office (USPTO) an application for patent term extension of its US patent covering its FDA-approved drug product Metvixia. US law permits patent term extension due to the lengthy FDA approval process, which had been the case for Metvixia.
The details can be read here.
No comments:
Post a Comment